According to GlobalData’s medical device pipeline database, 40 Vascular Access Devices for Hemodialysis devices are in various stages of development globally. GlobalData’s report Vascular Access Devices for Hemodialysis provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 23 are in active development, while the remaining 18 are in an inactive stage of development. There are 11 products in the early stages of development, and the remaining 12 are in the late stages of development.
Vascular access devices are medical devices that are used to provide hemodialysis treatment to patients. Patients with renal failure can receive hemodialysis treatment using vascular access devices that allow accessibility to the bloodstream. Vascular Access Devices for Hemodialysis include AV Fistula Needles, Hemodialysis Grafts, Vascular Covered Stents, and Hemodialysis Catheters. One unit refers to One vascular access device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Vascular Access Devices for Hemodialysis pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Vascular Access Devices for Hemodialysis devices. Overall, most of these Vascular Access Devices for Hemodialysis pipeline devices are being developed by private entities.
Key players involved in the active development of Vascular Access Devices for Hemodialysis include Humacyte, Phase One Medical, Phraxis, RegenMedTX, Shanghai Hongpu Medical Equipment, Silmag, TEI Biosciences, University of Arizona, University of California and University of Colorado.
For a complete picture of the developmental pipeline for Vascular Access Devices for Hemodialysis devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
